Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elad Sharon

Showing results (71-80 of 191) with videos related to

Pageof 20
Sort By:
Journal of the National Cancer Institute|August 12, 2023
The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapiesAnanth Annapragada, Andrew G Sikora, Himangi Marathe, et al.
Science Advances|August 3, 2022
Cross-species identification of cancer resistance-associated genes that may mediate human cancer riskNishanth Ulhas Nair, Kuoyuan Cheng, Lamis Naddaf, et al.
Cancer Immunology Research|June 8, 2026
Cancer chemo-immunotherapy: time will tellSam O Kleeman, Yosef Riazat-Kesh, Richard Carvajal, et al.
Journal for Immunotherapy of Cancer|October 21, 2018
Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statementApostolia M Tsimberidou, Laura A Levit, Richard L Schilsky, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2023
The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990-2018Nadia Howlader, Elad Sharon, Manami Bhattacharya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation ProgramAbdul Rafeh Naqash, Melissa Y Y Moey, Xiao-Wei Cherie Tan, et al.
Molecular Ecology|September 18, 2018
Species-complex diversification and host-plant associations in Bemisia tabaci: A plant-defence, detoxification perspective revealed by RNA-Seq analysesOsnat Malka, Diego Santos-Garcia, Ester Feldmesser, et al.
JNCI Cancer Spectrum|July 31, 2018
The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for ManagementMonica Girotra, Aaron Hansen, Azeez Farooki, et al.
Journal for Immunotherapy of Cancer|May 3, 2023
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designsTian Zhang, Patrick M Forde, Ryan J Sullivan, et al.
Breast (Edinburgh, Scotland)|January 5, 2019
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytesNancy Tray, Jessica Taff, Baljit Singh, et al.
Pageof 20

Showing results (71-80 of 191) with videos related to

Sort By:
Pageof 20
Journal of the National Cancer Institute|August 12, 2023
The Cancer Moonshot Immuno-Oncology Translational Network at 5: accelerating cancer immunotherapiesAnanth Annapragada, Andrew G Sikora, Himangi Marathe, et al.
Science Advances|August 3, 2022
Cross-species identification of cancer resistance-associated genes that may mediate human cancer riskNishanth Ulhas Nair, Kuoyuan Cheng, Lamis Naddaf, et al.
Cancer Immunology Research|June 8, 2026
Cancer chemo-immunotherapy: time will tellSam O Kleeman, Yosef Riazat-Kesh, Richard Carvajal, et al.
Journal for Immunotherapy of Cancer|October 21, 2018
Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statementApostolia M Tsimberidou, Laura A Levit, Richard L Schilsky, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 3, 2023
The Impact of Improved Treatments on Survival of Adult U.S. Leukemia Patients: 1990-2018Nadia Howlader, Elad Sharon, Manami Bhattacharya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2022
Major Adverse Cardiac Events With Immune Checkpoint Inhibitors: A Pooled Analysis of Trials Sponsored by the National Cancer Institute-Cancer Therapy Evaluation ProgramAbdul Rafeh Naqash, Melissa Y Y Moey, Xiao-Wei Cherie Tan, et al.
Molecular Ecology|September 18, 2018
Species-complex diversification and host-plant associations in Bemisia tabaci: A plant-defence, detoxification perspective revealed by RNA-Seq analysesOsnat Malka, Diego Santos-Garcia, Ester Feldmesser, et al.
JNCI Cancer Spectrum|July 31, 2018
The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for ManagementMonica Girotra, Aaron Hansen, Azeez Farooki, et al.
Journal for Immunotherapy of Cancer|May 3, 2023
Addressing resistance to PD-1/PD-(L)1 pathway inhibition: considerations for combinatorial clinical trial designsTian Zhang, Patrick M Forde, Ryan J Sullivan, et al.
Breast (Edinburgh, Scotland)|January 5, 2019
Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytesNancy Tray, Jessica Taff, Baljit Singh, et al.
Pageof 20